Legal News
Doc who designed DePuy’s metal hip tells jury he wouldn’t implant the device today
Kentucky cardiologist invokes wartime statute in Medicare kickbacks case
A whistleblower cardiologist from Kentucky wants a federal judge to bar a move to dismiss his lawsuit alleging a kickbacks scheme that defrauded Medicare, arguing that the statute of limitations should be extended because his lawsuit was filed while the U.S. was at war in Iraq.
Dr. Tullio Emanuele accused Medicor Assoc., several affiliates and 5 former colleagues of engaging in a scheme to defraud the government by setting up fake "medical directorship contracts" to pay the physicians $75,000 a year in return for virtually no work, according to court documents.
C.R. Bard loses patent round, $25M hernia insurance decision
Updated: Justice Dept., ArthroCare get another extension in criminal probe
Updated April 1, 2013, at 2:10 p.m. with stock activity.
ArthroCare (NSDQ:ARTC) and the U.S. Justice Dept. gave themselves until the end of May to hash out a deal over a criminal probe into ArthroCare’s spinal business.
More claims that J&J knew of hip implant troubles long before issuing a recall
Appeals court hands Abbott a win in stent patent battle with Johnson & Johnson’s Cordis
Abbott (NYSE:ABT) held on to a win in its patent infringement war with Johnson & Johnson‘s (NYSE:JNJ) Cordis Corp. after a federal appeals court upheld a lower court ruling last month.
ResMed takes aim at APEX Medical over respiratory device patents
Covidien wins $177M from Johnson & Johnson’s Ethicon Endo-Surgery in ultrasound scalpel spat
UPDATED March 29, 2013, with comment from Covidien.
Intuitive Surgical can’t dodge robot-assisted surgery training lawsuit
A Washington judge this week threw out Intuitive Surgical’s (NSDQ:ISRG) bid to dismiss a lawsuit claiming the company failed to provide doctors with sufficient training on the da Vinci robot-assisted surgical system.
CardioReady cautions FDA on new review for public defibrillators | MassDevice.com On Call
MASSDEVICE ON CALL — The FDA this month issued a new proposal on the regulatory oversight of automated external defibrillators, but at least 1 medical device maker is worried that enhanced oversight may harm public safety.
Philadelphia-based CardioReady, maker of AED systems, urged that the FDA ensure that any new oversight not jeopardize the proliferation of AEDs, in the interest of public health.